AlphaOS

Intelligence coverage: 55%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

WINT

WINDTREE THERAPEUTICS INC /DE/

Healthcare · Biological Products, (No Diagnostic Substances)

$0.11Aug 19, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Limited proprietary earnings coverage for WINT yet — signals will sharpen as filings and earnings are ingested.

Pipeline evidence · 16d ago

WINT's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on WINT.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest Intelligence

Updated

What happened recently for WINDTREE THERAPEUTICS INC /DE/ (WINT) — events, not interpretation.

Event
Last session August 19, 2026 at $0.11.
Source
Market data

Research & analysis only — not investment advice.

Building company intelligence…

WINDTREE THERAPEUTICS INC /DE/ (WINT)

Healthcare · Biological Products, (No Diagnostic Substances)

Investment Snapshot above is the primary AlphaOS analysis for WINDTREE THERAPEUTICS INC /DE/ — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:
Healthcare
Industry:
Biological Products, (No Diagnostic Substances)
Market cap:
$3.71M
Revenue:
$198,000

WINT earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow WINDTREE THERAPEUTICS INC /DE/ through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Related stock research

Connected companies and research pages from the AlphaOS knowledge graph.